HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Krzysztof Selmaj Selected Research
Krzysztof Selmaj Research Topics
Disease
49
Multiple Sclerosis
12/2023 - 01/2002
28
Relapsing-Remitting Multiple Sclerosis
12/2023 - 11/2003
9
Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/2014 - 12/2002
4
Infections
01/2022 - 10/2015
4
Neoplasms (Cancer)
01/2017 - 01/2006
3
Inflammation (Inflammations)
03/2022 - 12/2002
3
Atrophy
03/2022 - 10/2008
3
Demyelinating Diseases (Demyelinating Disease)
01/2021 - 02/2008
3
Necrosis
01/2006 - 11/2002
2
Exanthema (Rash)
10/2015 - 06/2013
2
Flushing
09/2015 - 09/2012
1
COVID-19
01/2022
1
Lymphopenia (Lymphocytopenia)
01/2022
1
Ganglion Cysts (Ganglion)
01/2022
1
Fever (Fevers)
10/2021
1
Splenomegaly
10/2021
1
Hypertriglyceridemia
10/2021
1
Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
10/2021
1
Cytopenia
10/2021
1
Chronic Progressive Multiple Sclerosis
01/2017
1
Respiratory Tract Infections (Respiratory Tract Infection)
01/2017
1
Transposition of Great Vessels (Great Vessels Transposition)
12/2016
1
Congenital Heart Defects (Congenital Heart Defect)
12/2016
1
Spontaneous Abortion (Miscarriage)
12/2016
1
Pneumonia (Pneumonitis)
07/2016
1
Ulcerative Colitis
07/2016
1
Urinary Tract Infections (Urinary Tract Infection)
07/2016
1
Injection Site Reaction
12/2015
1
Eczema
10/2015
1
Autoimmune Hepatitis
05/2014
1
Neuromyelitis Optica (Devic's Disease)
07/2013
1
Psoas Abscess
06/2013
1
Abdominal Pain (Pain, Abdominal)
09/2012
1
Diarrhea
09/2012
1
Nausea
09/2012
1
Hypoglycemia (Reactive Hypoglycemia)
10/2010
1
Diabetic Angiopathies (Diabetic Angiopathy)
10/2010
1
Uremia
10/2010
1
Acidosis
10/2010
1
Bradycardia
02/2010
1
Hypertension (High Blood Pressure)
02/2010
1
Atrioventricular Block
02/2010
1
Macular Edema
02/2010
1
Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
08/2008
Drug/Important Bio-Agent (IBA)
10
Dimethyl Fumarate
IBA
01/2022 - 09/2012
7
Interferon beta-1a
FDA Link
01/2018 - 11/2003
5
Glatiramer Acetate (Copaxone)
FDA Link
10/2021 - 05/2006
5
Daclizumab (Zenapax)
FDA Link
10/2020 - 06/2013
5
Antigens
IBA
03/2015 - 06/2004
4
Fingolimod Hydrochloride (FTY720)
FDA Link
01/2022 - 02/2010
4
ocrelizumab
IBA
10/2021 - 01/2017
4
Biomarkers (Surrogate Marker)
IBA
01/2020 - 01/2007
4
Gadolinium
IBA
01/2018 - 09/2014
4
Peptides (Polypeptides)
IBA
10/2014 - 10/2007
3
teriflunomide
IBA
01/2022 - 01/2020
3
daclizumab HYP
IBA
10/2015 - 06/2013
3
Interferons
IBA
11/2014 - 05/2006
3
Ligands
IBA
01/2010 - 11/2002
3
Amyloid Precursor Protein Secretases (beta-Secretase)
IBA
02/2008 - 12/2005
2
Cladribine
FDA Link
Generic
12/2023 - 01/2022
2
diroximel fumarate
IBA
12/2023 - 01/2020
2
Tablets
IBA
12/2023 - 01/2022
2
Natalizumab (Tysabri)
FDA Link
01/2023 - 07/2013
2
Monoclonal Antibodies
IBA
01/2023 - 08/2010
2
Retinaldehyde (Retinal)
IBA
01/2022 - 10/2008
2
Antibodies
IBA
01/2021 - 10/2017
2
Fumarates
IBA
01/2020 - 02/2014
2
siponimod
IBA
09/2016 - 08/2013
2
Enzymes
IBA
07/2016 - 02/2010
2
Transaminases (Aminotransferases)
IBA
10/2015 - 09/2012
2
Notch Receptors
IBA
01/2010 - 02/2008
2
Proteins (Proteins, Gene)
FDA Link
01/2008 - 09/2004
2
Chemokines
IBA
09/2004 - 12/2002
1
nitazoxanide (NTZ)
FDA Link
01/2023
1
Biosimilar Pharmaceuticals
IBA
01/2023
1
temelimab
IBA
03/2022
1
ublituximab
IBA
01/2022
1
Ferritins (Ferritin)
IBA
10/2021
1
Myelin-Oligodendrocyte Glycoprotein
IBA
01/2021
1
ofatumumab
FDA Link
01/2020
1
Cytidine Diphosphate (CDP)
IBA
12/2018
1
Cholesterol
IBA
10/2017
1
Lipids
IBA
10/2017
1
Lisinopril (Prinivil)
FDA Link
Generic
12/2016
1
Neuroprotective Agents
IBA
06/2016
1
Generic Drugs
IBA
12/2015
1
Interleukin-2 (IL2)
IBA
10/2015
1
Tetanus Toxoid (Vaccine, Tetanus)
FDA Link
03/2015
1
Influenza Vaccines (Influenza Vaccine)
FDA Link
03/2015
1
Indicators and Reagents (Reagents)
IBA
12/2014
1
Chemokine Receptors
IBA
11/2014
1
Therapeutic Uses
IBA
08/2013
1
Interferon-beta
IBA
04/2011
1
Uremic Toxins
IBA
10/2010
1
Hypoglycemic Agents (Hypoglycemics)
IBA
10/2010
1
Glucose (Dextrose)
FDA Link
Generic
10/2010
1
Alemtuzumab (Campath)
FDA Link
08/2010
1
myosin-binding protein C
IBA
08/2008
Therapy/Procedure
11
Therapeutics
01/2023 - 11/2007
1
Subcutaneous Injections
06/2013